X66, a novel N-terminal heat shock protein 90 inhibitor, exerts antitumor effects without induction of heat shock response
Zhixin Zhao(Chinese Academy of Sciences), Liguang Lou(Shanghai Institute of Materia Medica)
Cited by 14
Related Papers
YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor‐2 tyrosine kinase with potent activity <i>in vitro</i> and <i>in vivo</i>
|Cancer Science|2011|519
Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor‐2 inhibitor
|Cancer Science|2018|368
Aberrant intracellular metabolism of T‐ <scp>DM</scp> 1 confers T‐ <scp>DM</scp> 1 resistance in human epidermal growth factor receptor 2‐positive gastric cancer cells
|Cancer Science|2017|67
Pharmacological characterization of hetrombopag, a novel orally active human thrombopoietin receptor agonist
|Journal of Cellular and Molecular Medicine|2018|59